|1.||Greer, Susanna F: 2 articles (01/2012 - 01/2010)|
|2.||Truax, Agnieszka D: 2 articles (01/2012 - 01/2010)|
|3.||Blanck, George: 2 articles (03/2009 - 02/2006)|
|4.||Osborne, Aaron R: 2 articles (03/2009 - 02/2006)|
|5.||Antonina, Sidoti: 1 article (08/2015)|
|6.||Antonio, Drago: 1 article (08/2015)|
|7.||Concetta, Crisafulli: 1 article (08/2015)|
|8.||Alessandro, Serretti: 1 article (08/2015)|
|9.||Marco, Calabrò: 1 article (08/2015)|
|10.||Hinds, David A: 1 article (06/2015)|
|1.||Parkinson Disease (Parkinson's Disease)
04/01/2015 - "Many studies have evaluated the association between the HLA-DRA rs3129882 A/G polymorphism and risk for Parkinson's disease (PD) in Chinese-based populations, however, published data remain inconclusive. "
04/01/2015 - "HLA-DRA rs3129882 A/G polymorphism was not a risk factor for Parkinson's disease in Chinese-based populations: a meta-analysis."
01/01/2015 - "As one of potential candidate genes for the risk of Parkinson's disease (PD), the HLA-DRA/PARK18 (rs3129882, A > G) gene has been studied extensively. "
12/01/2014 - "HLA-DRA is associated with Parkinson's disease in Iranian population."
06/01/2014 - "Genome-wide association studies identified PARK16 variants rs823128 and rs947211, PARK17/GAK rs11248051 and PARK18/HLA-DRA rs3129882 as risk factors for Parkinson's disease (PD). "
01/01/2015 - "HLA-DRA variants predict penicillin allergy in genome-wide fine-mapping genotyping."
02/01/2013 - "ICSNPathway analysis identified four candidate causal SNPs, four genes, and 21 candidate causal pathways, which in total provided four hypothetical biologic mechanisms: (1) rs7192 (nonsynonymous coding) to HLA-DRA to 21 pathways, such as, the role of eosinophils in the chemokine network of allergy, Th1/Th2 differentiation, and asthma (nominal p ≤ 0.001, FDR p ≤ 0.01); (2) rs20541 (nonsynonymous coding) to IL13 to asthma and cytokines and inflammatory response (nominal p<0.001, FDR p ≤ 0.008); (3) rs1058808 (frameshift coding) to ERBB2 to transmembrane receptor activity (nominal p=0.001, FDR p=0.01); (4) rs17350764 (nonsynonymous coding (deleterious)) to OR52J3 to transmembrane receptor activity (nominal p=0.001, FDR p=0.01). "
01/01/2015 - "HLA-DRA rs7192 and rs8084 were significantly associated with allergy to penicillins and amoxicillin (P = 6.0 × 10(-4) and P = 4.0 × 10(-4), respectively) but not to cephalosporins in the replication study. "
01/01/2015 - "Gene variants of HLA-DRA and the HLA-DRA | HLA-DRB5 interregion were significant predictors of allergy to penicillins but not to cephalosporins. "
06/21/1994 - "To study the immune function of HLA-DR4 and attempt to generate a murine model of rheumatoid arthritis we have produced triple transgenic mice expressing HLA-DRA*0101, -DRB1*0401, and human CD4. "
11/01/2011 - "HLA-DRA, total CIITA, and CIITA PIII messenger RNA levels were significantly increased in synovial tissue samples from patients with rheumatoid arthritis compared with the levels in tissue from patients with osteoarthritis. "
|4.||Ovarian Neoplasms (Ovarian Cancer)
|5.||Disease Susceptibility (Diathesis)
|1.||HLA-DR Antigens (HLA-DR)
|2.||HLA-DR4 Antigen (HLA DR4 Antigen)
|4.||Cephalosporins (Cephalosporin Antibiotics)
|6.||Messenger RNA (mRNA)
|8.||Interferon-gamma (Interferon, gamma)
|9.||DNA (Deoxyribonucleic Acid)
|10.||HLA-DPA1 (HLA DPA1)